AIDP Granted U.S. Patents for Magtein

August 14, 2012

1 Min Read
AIDP Granted U.S. Patents for Magtein

INDUSTRY, Calif.AIDP Inc. received two patents for magnesium compositions and uses for cognitive function and neurological disorders. The company distributes Magtein magnesium L-threonate, a cognitive health ingredient.

The recently awarded patents protect Magteins magnesium compositions and their use for any magnesium L-threonate-containing food, nutritional supplements and drugs. Magtein is a magnesium-based functional ingredient designed to improve memory, focus and overall cognitive health, including ameliorating the effects of a neurological disorder. AIDP began distributing Magtein in June 2011.

The products are targeted at people suffering from loss of cognitive function, loss of memory, Alzheimer's disease, depression, attention deficit hyperactivity disorder, Amyotrophic lateral sclerosis (ALS), Parkinson's disease, migraine, anxiety disorder and mood disorder.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like